Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
62/100
Pipeline Velocity
42/100
Trial Completion Rate
86/100
Pipeline Concentration
100/100
Pipeline Freshness
70/100
Activity
Last 14 days
Zero-cost Radiation Protection Method to Reduce Radiation Exposure of Interventional Cardiologists During Transradial Percutaneous Coronary Procedures (FREEPADRAD Trial)
Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
Histological Effects of Subepithelial Vaginal Platelet-Rich Plasma for Women With Genitourinary Syndrome of Menopause and Pelvic Organ Prolapse: A Prospective Split-Vagina Controlled Study
Effectiveness of Virtual Reality in Functionality of Upper Limb in Critically Ill Patients (EVOLUTION)
Association Between Intraoperative Distractions, Surgeon Anxiety and Task Load, Team Collaboration, and Intraoperative Adverse Events: The ORCHESTRA Study
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)